Silence Therapeutics (SLN) Profit After Tax (2020 - 2025)
Historic Profit After Tax for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to -$21.0 million.
- Silence Therapeutics' Profit After Tax rose 4103.65% to -$21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.5 million, marking a year-over-year increase of 1528.64%. This contributed to the annual value of -$45.3 million for FY2024, which is 1644.72% up from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Profit After Tax is -$21.0 million, which was up 4103.65% from -$27.4 million recorded in Q2 2025.
- Silence Therapeutics' Profit After Tax's 5-year high stood at $12.3 million during Q4 2024, with a 5-year trough of -$35.5 million in Q3 2024.
- In the last 5 years, Silence Therapeutics' Profit After Tax had a median value of -$16.6 million in 2021 and averaged -$16.1 million.
- Its Profit After Tax has fluctuated over the past 5 years, first soared by 16622.85% in 2024, then tumbled by 113399.65% in 2025.
- Over the past 5 years, Silence Therapeutics' Profit After Tax (Quarter) stood at -$15.1 million in 2021, then dropped by 16.64% to -$17.7 million in 2022, then decreased by 5.23% to -$18.6 million in 2023, then surged by 166.23% to $12.3 million in 2024, then tumbled by 270.36% to -$21.0 million in 2025.
- Its Profit After Tax stands at -$21.0 million for Q3 2025, versus -$27.4 million for Q2 2025 and -$28.5 million for Q1 2025.